AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
AngioDynamics (ANGO) Tops Q2 EPS by 5c, Revenues Beat; Offers FY19 EPS/Revenue Outlook
January 4, 2019 7:09 AM ESTAngioDynamics (NASDAQ: ANGO) reported Q2 EPS of $0.22, $0.05 better than the analyst estimate of $0.17. Revenue for the quarter came in at $91.5 million versus the consensus estimate of $89.24 million.
Net sales of $91.5 million, an increase of 5.5% year over yearGross margin expanded 440 basis points year over year to 53.7%GAAP EPS of $0.06 per share; adjusted EPS of $0.22 per... More